92 related articles for article (PubMed ID: 25354534)
1. The key role of PML in IFN-α induced cellular senescence of human mesenchymal stromal cells.
Fu S; Wei J; Wang G; Wang B; Wang Y; Lai X; Huang H
Int J Oncol; 2015 Jan; 46(1):351-9. PubMed ID: 25354534
[TBL] [Abstract][Full Text] [Related]
2. Pml and TAp73 interacting at nuclear body mediate imatinib-induced p53-independent apoptosis of chronic myeloid leukemia cells.
Liu JH; Liu CC; Yen CC; Gau JP; Wang WS; Tzeng CH
Int J Cancer; 2009 Jul; 125(1):71-7. PubMed ID: 19291793
[TBL] [Abstract][Full Text] [Related]
3. PML overexpression inhibits proliferation and promotes the osteogenic differentiation of human mesenchymal stem cells.
Sun J; Fu S; Zhong W; Huang H
Oncol Rep; 2013 Dec; 30(6):2785-94. PubMed ID: 24101171
[TBL] [Abstract][Full Text] [Related]
4. PML mediates IFN-alpha-induced apoptosis in myeloma by regulating TRAIL induction.
Crowder C; Dahle Ø; Davis RE; Gabrielsen OS; Rudikoff S
Blood; 2005 Feb; 105(3):1280-7. PubMed ID: 15459016
[TBL] [Abstract][Full Text] [Related]
5. Knocking down PML impairs p53 signaling transduction pathway and suppresses irradiation induced apoptosis in breast carcinoma cell MCF-7.
Bao-Lei T; Zhu-Zhong M; Yi S; Jun-Jie Q; Yan D; Hua L; Bin L; Guo-Wei Z; Zhi-Xian S
J Cell Biochem; 2006 Feb; 97(3):561-71. PubMed ID: 16215989
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus core protein inhibits tumor suppressor protein promyelocytic leukemia function in human hepatoma cells.
Herzer K; Weyer S; Krammer PH; Galle PR; Hofmann TG
Cancer Res; 2005 Dec; 65(23):10830-7. PubMed ID: 16322229
[TBL] [Abstract][Full Text] [Related]
7. IFN-alpha-induced apoptosis in hepatocellular carcinoma involves promyelocytic leukemia protein and TRAIL independently of p53.
Herzer K; Hofmann TG; Teufel A; Schimanski CC; Moehler M; Kanzler S; Schulze-Bergkamen H; Galle PR
Cancer Res; 2009 Feb; 69(3):855-62. PubMed ID: 19141642
[TBL] [Abstract][Full Text] [Related]
8. Telomerase suppression initiates PML-dependent p53 activation to inhibit bladder cancer cell growth.
Xue Y; Li L; Zhang D; Wu K; Guo P; Zeng J; Wang X; He D
Oncol Rep; 2010 Dec; 24(6):1551-9. PubMed ID: 21042751
[TBL] [Abstract][Full Text] [Related]
9. PML regulates p53 acetylation and premature senescence induced by oncogenic Ras.
Pearson M; Carbone R; Sebastiani C; Cioce M; Fagioli M; Saito S; Higashimoto Y; Appella E; Minucci S; Pandolfi PP; Pelicci PG
Nature; 2000 Jul; 406(6792):207-10. PubMed ID: 10910364
[TBL] [Abstract][Full Text] [Related]
10. A CK2-dependent mechanism for degradation of the PML tumor suppressor.
Scaglioni PP; Yung TM; Cai LF; Erdjument-Bromage H; Kaufman AJ; Singh B; Teruya-Feldstein J; Tempst P; Pandolfi PP
Cell; 2006 Jul; 126(2):269-83. PubMed ID: 16873060
[TBL] [Abstract][Full Text] [Related]
11. Epigallocatechin-3-gallate prevents oxidative stress-induced cellular senescence in human mesenchymal stem cells via Nrf2.
Shin JH; Jeon HJ; Park J; Chang MS
Int J Mol Med; 2016 Oct; 38(4):1075-82. PubMed ID: 27498709
[TBL] [Abstract][Full Text] [Related]
12. AXIN is an essential co-activator for the promyelocytic leukemia protein in p53 activation.
Li Q; He Y; Wei L; Wu X; Wu D; Lin S; Wang Z; Ye Z; Lin SC
Oncogene; 2011 Mar; 30(10):1194-204. PubMed ID: 21057547
[TBL] [Abstract][Full Text] [Related]
13. Involvement of promyelocytic leukemia protein in the ethanol-induced apoptosis in mouse embryo fibroblasts.
Wang LH; Yang JY; Cui W; Shin YK; Wu CF
Yakugaku Zasshi; 2008 Jul; 128(7):1067-71. PubMed ID: 18591875
[TBL] [Abstract][Full Text] [Related]
14. Direct transcriptional activation of promyelocytic leukemia protein by IFN regulatory factor 3 induces the p53-dependent growth inhibition of cancer cells.
Kim TK; Lee JS; Oh SY; Jin X; Choi YJ; Lee TH; Lee Eh; Choi YK; You S; Chung YG; Lee JB; DePinho RA; Chin L; Kim H
Cancer Res; 2007 Dec; 67(23):11133-40. PubMed ID: 18056437
[TBL] [Abstract][Full Text] [Related]
15. Human fibroblasts require the Rb family of tumor suppressors, but not p53, for PML-induced senescence.
Mallette FA; Goumard S; Gaumont-Leclerc MF; Moiseeva O; Ferbeyre G
Oncogene; 2004 Jan; 23(1):91-9. PubMed ID: 14712214
[TBL] [Abstract][Full Text] [Related]
16. PML is induced by oncogenic ras and promotes premature senescence.
Ferbeyre G; de Stanchina E; Querido E; Baptiste N; Prives C; Lowe SW
Genes Dev; 2000 Aug; 14(16):2015-27. PubMed ID: 10950866
[TBL] [Abstract][Full Text] [Related]
17. PML protein association with specific nucleolar structures differs in normal, tumor and senescent human cells.
Janderová-Rossmeislová L; Nováková Z; Vlasáková J; Philimonenko V; Hozák P; Hodný Z
J Struct Biol; 2007 Jul; 159(1):56-70. PubMed ID: 17428679
[TBL] [Abstract][Full Text] [Related]
18. [A new player in PML-mediated cellular senescence: TBX2 gets into the loop].
Martin N; Dejean A; Bischof O
Med Sci (Paris); 2012 Mar; 28(3):248-50. PubMed ID: 22480643
[No Abstract] [Full Text] [Related]
19. The promyelocytic leukemia protein functions as a negative regulator of IFN-gamma signaling.
Choi YH; Bernardi R; Pandolfi PP; Benveniste EN
Proc Natl Acad Sci U S A; 2006 Dec; 103(49):18715-20. PubMed ID: 17121994
[TBL] [Abstract][Full Text] [Related]
20. Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence.
Langley E; Pearson M; Faretta M; Bauer UM; Frye RA; Minucci S; Pelicci PG; Kouzarides T
EMBO J; 2002 May; 21(10):2383-96. PubMed ID: 12006491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
